v3.26.1
Supplemental Financial Information
3 Months Ended
Mar. 31, 2026
Condensed Financial Information Disclosure [Abstract]  
Supplemental Financial Information 16. Supplemental Financial Information
The following supplemental financial information illustrates the consolidating effects of the Consolidated Funds on the
Company’s financial position as of March 31, 2026 and December 31, 2025 and results of operations for the three months
ended March 31, 2026 and 2025. The supplemental statement of cash flows is presented without effects of the Consolidated
Funds.
 
As of March 31, 2026
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Assets
Cash and cash equivalents
$1,673.2
$
$
$1,673.2
Cash and cash equivalents held at Consolidated Funds
1,081.0
1,081.0
Investments, including accrued performance allocations of $6,865.4
11,449.9
(984.6)
10,465.3
Investments of Consolidated Funds
14,326.8
14,326.8
Due from affiliates and other receivables, net
1,070.1
(301.0)
769.1
Due from affiliates and other receivables of Consolidated Funds, net
356.7
356.7
Fixed assets, net
234.9
234.9
Lease right-of-use assets, net
332.9
332.9
Deposits and other
96.2
2.2
98.4
Intangible assets, net
473.6
473.6
Deferred tax assets
30.1
30.1
Total assets
$15,360.9
$15,766.7
$(1,285.6)
$29,842.0
Liabilities and equity
Debt obligations
$3,001.6
$
$
$3,001.6
Loans payable of Consolidated Funds
11,434.1
(285.4)
11,148.7
Accounts payable, accrued expenses and other liabilities
478.3
478.3
Accrued compensation and benefits
4,911.8
4,911.8
Due to affiliates
218.8
7.6
226.4
Deferred revenue
358.2
358.2
Deferred tax liabilities
55.2
55.2
Other liabilities of Consolidated Funds
1,719.0
(0.6)
1,718.4
Lease liabilities
466.8
466.8
Accrued giveback obligations
102.0
102.0
Total liabilities
9,592.7
13,160.7
(286.0)
22,467.4
Common stock
3.6
3.6
Additional paid-in capital
4,408.4
1,025.5
(1,025.5)
4,408.4
Retained earnings
1,172.7
1,172.7
Accumulated other comprehensive loss
(230.9)
23.8
25.9
(181.2)
Non-controlling interests in consolidated entities
414.4
1,556.7
1,971.1
Total equity
5,768.2
2,606.0
(999.6)
7,374.6
Total liabilities and equity
$15,360.9
$15,766.7
$(1,285.6)
$29,842.0
As of December 31, 2025
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Assets
Cash and cash equivalents
$1,970.2
$
$
$1,970.2
Cash and cash equivalents held at Consolidated Funds
1,235.1
1,235.1
Investments, including accrued performance allocations of $7,620.3
12,219.6
(1,066.9)
11,152.7
Investments of Consolidated Funds
12,519.8
12,519.8
Due from affiliates and other receivables, net
1,135.0
(300.2)
834.8
Due from affiliates and other receivables of Consolidated Funds, net
206.4
206.4
Fixed assets, net
224.9
224.9
Lease right-of-use assets, net
331.9
331.9
Deposits and other
98.2
2.7
100.9
Intangible assets, net
507.1
507.1
Deferred tax assets
32.2
32.2
Total assets
$16,519.1
$13,964.0
$(1,367.1)
$29,116.0
Liabilities and equity
Debt obligations
$2,997.0
$
$
$2,997.0
Loans payable of Consolidated Funds
10,712.4
(286.4)
10,426.0
Accounts payable, accrued expenses and other liabilities
543.7
543.7
Accrued compensation and benefits
5,849.4
5,849.4
Due to affiliates
197.8
6.1
203.9
Deferred revenue
129.2
129.2
Deferred tax liabilities
106.3
106.3
Other liabilities of Consolidated Funds
1,260.7
(0.3)
1,260.4
Lease liabilities
470.2
470.2
Accrued giveback obligations
72.8
72.8
Total liabilities
10,366.4
11,979.2
(286.7)
22,058.9
Common stock
3.6
3.6
Additional paid-in capital
4,285.8
1,099.2
(1,099.2)
4,285.8
Retained earnings
1,642.3
1,642.3
Accumulated other comprehensive loss
(213.1)
24.1
18.8
(170.2)
Non-controlling interests in consolidated entities
434.1
861.5
1,295.6
Total equity
6,152.7
1,984.8
(1,080.4)
7,057.1
Total liabilities and equity
$16,519.1
$13,964.0
$(1,367.1)
$29,116.0
 
 
 
Three Months Ended March 31, 2026
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Revenues
Fund management fees
$596.0
$
$(12.0)
$584.0
Incentive fees
51.7
51.7
Investment income (loss)
Performance allocations
(680.0)
(1.1)
(681.1)
Principal investment income (loss)
(5.2)
69.6
64.4
Total investment loss
(685.2)
68.5
(616.7)
Interest and other income
63.1
(7.8)
55.3
Interest and other income of Consolidated Funds
179.7
179.7
Total revenues
25.6
179.7
48.7
254.0
Expenses
Compensation and benefits
Cash-based compensation and benefits
227.1
227.1
Equity-based compensation
119.8
119.8
Performance allocations and incentive fee related compensation
(367.9)
(367.9)
Total compensation and benefits
(21.0)
(21.0)
General, administrative and other expenses
184.5
0.1
184.6
Interest
38.6
38.6
Interest and other expenses of Consolidated Funds
178.3
(11.9)
166.4
Total expenses
202.1
178.3
(11.8)
368.6
Other loss
Net investment loss of Consolidated Funds
(64.4)
(64.4)
Loss before benefit for income taxes
(176.5)
(63.0)
60.5
(179.0)
Benefit for income taxes
(37.1)
(37.1)
Net loss
(139.4)
(63.0)
60.5
(141.9)
Net loss attributable to non-controlling interests in consolidated
entities
(7.2)
(2.5)
(9.7)
Net loss attributable to The Carlyle Group Inc.
$(132.2)
$(63.0)
$63.0
$(132.2)
Three Months Ended March 31, 2025
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Revenues
Fund management fees
$594.4
$
$(8.3)
$586.1
Incentive fees
43.3
(0.1)
43.2
Investment income
Performance allocations
223.4
(0.5)
222.9
Principal investment loss
(60.5)
(2.6)
(63.1)
Total investment income
162.9
(3.1)
159.8
Interest and other income
57.2
(6.6)
50.6
Interest and other income of Consolidated Funds
133.4
133.4
Total revenues
857.8
133.4
(18.1)
973.1
Expenses
Compensation and benefits
Cash-based compensation and benefits
218.4
218.4
Equity-based compensation
103.5
103.5
Performance allocations and incentive fee related compensation
171.4
171.4
Total compensation and benefits
493.3
493.3
General, administrative and other expenses
173.7
(0.1)
173.6
Interest
27.8
27.8
Interest and other expenses of Consolidated Funds
130.8
(17.3)
113.5
Total expenses
694.8
130.8
(17.4)
808.2
Other income
Net investment income of Consolidated Funds
6.1
6.1
Income before provision for income taxes
163.0
8.7
(0.7)
171.0
Provision for income taxes
12.4
12.4
Net income
150.6
8.7
(0.7)
158.6
Net income attributable to non-controlling interests in consolidated
entities
20.6
8.0
28.6
Net income attributable to The Carlyle Group Inc.
$130.0
$8.7
$(8.7)
$130.0
 
 
Three Months Ended March 31,
 
2026
2025
 
(Dollars in millions)
Cash flows from operating activities
Net income (loss)
$(139.4)
$150.6
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization
50.5
46.9
Equity-based compensation
119.8
103.5
Non-cash performance allocations and incentive fees
282.0
14.5
Non-cash principal investment (income) loss
17.4
69.6
Other non-cash amounts
(2.1)
12.6
Purchases of investments
(328.7)
(290.9)
Proceeds from the sale of investments
358.8
155.1
Payments of contingent consideration
(1.0)
Change in deferred taxes, net
(45.4)
(29.4)
Change in due from affiliates and other receivables
(1.1)
12.7
Change in deposits and other
7.1
(10.8)
Change in accounts payable, accrued expenses and other liabilities
(66.1)
(25.4)
Change in accrued compensation and benefits
(461.2)
(327.7)
Change in due to affiliates
18.0
6.5
Change in lease right-of-use assets and lease liabilities
(4.5)
(2.8)
Change in deferred revenue
229.8
280.2
Net cash provided by operating activities
34.9
164.2
Cash flows from investing activities
Purchases of fixed assets, net
(28.1)
(16.7)
Net cash used in investing activities
(28.1)
(16.7)
Cash flows from financing activities
Payments on CLO borrowings
(22.5)
(14.6)
Proceeds from CLO borrowings, net of financing costs
32.4
15.1
Dividends to common stockholders
(126.4)
(126.4)
Contributions from non-controlling interest holders
51.7
57.7
Distributions to non-controlling interest holders
(59.6)
(16.9)
Common shares repurchased and net share settlement of equity-based awards
(204.8)
(176.5)
Change in due to/from affiliates financing activities
36.9
42.3
Net cash used in financing activities
(292.3)
(219.3)
Effect of foreign exchange rate changes
(5.4)
4.6
Decrease in cash, cash equivalents and restricted cash
(290.9)
(67.2)
Cash, cash equivalents and restricted cash, beginning of period
1,973.6
1,266.5
Cash, cash equivalents and restricted cash, end of period
$1,682.7
$1,199.3
Reconciliation of cash, cash equivalents and restricted cash, end of period:
  Cash and cash equivalents
$1,673.2
$1,190.3
  Restricted cash
9.5
9.0
  Total cash, cash equivalents and restricted cash, end of period
$1,682.7
$1,199.3
  Cash and cash equivalents held at Consolidated Funds
$1,081.0
$570.9